Published in Acta Diabetol on August 12, 2009
Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol (2005) 1.62
TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol (2010) 1.51
Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes. Haematologica (2004) 1.48
Tadalafil versus solifenacin for persistent storage symptoms after prostate surgery in patients with erectile dysfunction: a prospective randomized study. Int J Urol (2011) 1.40
The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care (2003) 1.38
Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J Immunoassay Immunochem (2008) 0.93
Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol Sci (2008) 0.89
Prognostic value of total atrial conduction time measured with tissue Doppler imaging to predict the maintenance of sinus rhythm after external electrical cardioversion of persistent atrial fibrillation. Echocardiography (2014) 0.82
Estimating excess glucose, sodium and water deficits in non-ketotic hyperglycaemia. Nephrol Dial Transplant (2007) 0.82
Peroxisome proliferator-activated receptor-gamma expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy--a pilot study. Rheumatology (Oxford) (2012) 0.81
Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism. Respir Med (2008) 0.80
Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome. Diabetes Metab Res Rev (2006) 0.80
DRESS syndrome with cerebral vasculitis. Intern Med (2013) 0.79
Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department. Eur Heart J Acute Cardiovasc Care (2014) 0.79
Complex movement disorders in primary antiphospholipid syndrome: a case report. J Neurol Sci (2009) 0.78
[Diagnosis and therapy of hyponatremia]. Ann Ital Med Int (2004) 0.77
Acute pseudogout following intravenous neridronate for osteoporosis. J Rheumatol (2010) 0.77
Progression from hidden to overt type 2 diabetes mellitus: significance of screening and importance of the laboratory. Clin Lab (2005) 0.75
Isolated supravalvular pulmonary stenosis: a rare echocardiographic finding. Echocardiography (2014) 0.75
Role of echocardiographic dyssynchrony parameters in predicting response to cardiac resynchronization therapy. J Cardiovasc Med (Hagerstown) (2015) 0.75
An improved method to compute the solute and water derangements of hyperglycaemia. Eur J Appl Physiol (2007) 0.75
Pseudo-myelofibrosis: a new clinical entity. Eur J Intern Med (2011) 0.75
A malignant fibroleiomyoma of the testis. Clin Lymphoma Myeloma (2006) 0.75
In vitro effect of cyclosporine-A on angiotensins secretion by glomerular cells. Nephrology (Carlton) (2008) 0.75
New method to compute mixed water and electrolyte changes in hyponatremia: a preliminary report. J Nephrol (2009) 0.75
Hyperosmolar coma due to exclusive glucose accumulation: recognition and computations. Nephrology (Carlton) (2009) 0.75
Treating high blood pressure: is reaching the target more important than the means? Yes, the target is more important. Eur J Intern Med (2010) 0.75
Periprostatic nerve block before ultrasound-guided prostate biopsy: a comparison of two local anesthetics. Arch Ital Urol Androl (2009) 0.75
[Herbs and cardiotoxic effects]. G Ital Cardiol (Rome) (2013) 0.75